AACE Media Center
The American Association of Clinical Endocrinologists (AACE) represents practicing clinicians and health care professionals who are experts in the treatment and management of endocrine and metabolic disorders. AACE welcomes the opportunity to provide disease state expertise and information via interviews with AACE member volunteers.
For media inquiries and/or interview requests, please contact: [email protected]
The American Association of Clinical Endocrinologists (AACE), the leading medical organization representing more than 6,000 experts in the care and treatment of diabetes patients, today announced plans to convene a conference of U.S. and international experts to examine the issue of diabetic ketoacidosis (DKA) among patients treated with SGLT2 inhibitors, a class of medications approved for use in adults with type 2 diabetes. AACE will conduct this meeting to provide answers to questions from its membership raised in response to recent case reports and publications on the subject.
While agreeing with the U.S. Preventive Services Task Force’s (USPSTF) assessment that more studies are needed to determine the effectiveness of screening for thyroid disease, the American Association of Clinical Endocrinologists (AACE), the nation’s largest collection of clinical endocrinologists, contends that aggressive case finding is an appropriate alternative in patient groups where thyroid risk factors are present.
The American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) organized a gathering of U.S. and international diabetes physicians, scientists, and other experts to conduct a rigorous examination of potential issues surrounding SGLT2i (sodium-glucose cotransporter-2 inhibitors), a class of prescription medicines used to lower blood sugar in adults with diabetes, and its possible relationship to diabetic ketoacidosis (DKA).
Most people wouldn’t equate a dentist office visit with being adiabetes diagnosis, but according to research presented today at the American Association of Clinical Endocrinologists’ 24th Annual Scientific and Clinical Congress that’s one of the most logical places to be screened for the chronic disease.
Endocrine leaders of the American Association of Clinical Endocrinologists, riding on the heels of a successful and unprecedented conference held last February in San Juan, Costa Rica, are discussing the results of the successful and unprecedented conference and how it will change the delivery of health care for patients in Latin America, Mexico and the Caribbean Basin for the better.
The American Association of Clinical Endocrinologists (AACE) has launched a new, online-only journal – AACE Clinical Case Reports (AACR) – dedicated to endocrine practice case reports, including commentary from noted endocrinology experts.
Two dedicated endocrinologists, experts in the care of patients with diabetes, have used their songwriting talents to co-write, produce, and record with a former American Idol performer and other recording artists, “Needle-Free”, an anthem of hope for patients with type1 diabetes and a message of awareness of the obstacles those patients face daily.
The American Association of Clinical Endocrinologists (AACE) secured approval of a resolution by the American Medical Association (AMA) House of Delegates that will that will secure the study of obesity education in medical schools and the develop recommendations to address gaps in obesity education to physicians.
Citing the lack of compelling evidence connecting testosterone replacement therapy (TRT) with cardiovascular events such as heart attack and stroke, physicians representing the American Association of Clinical Endocrinologists (AACE) today issued a position statement questioning claims that testosterone replacement therapy (TRT) increases the risk of cardiovascular disease among users.
The American Association of Clinical Endocrinologists (AACE) today announced its Consensus Conference on Continuous Glucose Monitoring (CGM) slated for Saturday, February 20, 2016 at the Hyatt Regency Capitol Hill in Washington, D.C.
The American Association of Clinical Endocrinologists (AACE) today announced the publication of new, expansive diabetes clinical practice guidelines and an updated diabetes algorithm to assist clinical caregivers with the medical management of patients with diabetes mellitus (DM).
In conjunction with January being Thyroid Awareness Month, the American College of Endocrinology (ACE) – the educational and scientific arm of the American Association of Clinical Endocrinologists (AACE) – has kicked off a year-long campaign to help people understand the importance of their thyroid, a butterfly-shaped endocrine gland located low in the front of the neck.
An estimated 29.1 million Americans (almost 10 percent of the total population) have diabetes, another 86 million citizens aged 20 or older suffer from prediabetes, and spending on diagnosed diabetes has increased 41 percent over five years, according to the Centers for Disease Control and Prevention (CDC).
Responding to requests from its international members to adapt medical guidelines and best-practice treatment algorithms to be more applicable for use in their home countries, the American Association of Clinical Endocrinologists (AACE) just concluded a first-of-its-kind conference where the foundation was laid to achieve culturally maximized quality of endocrine care for patients across and within all borders.
The American Association of Clinical Endocrinologists (AACE) will convene the first-ever, Pan-American Scientific Symposium: Clinical Endocrinology in Latin America on February 26-28 in San Jose, Costa Rica.
A thyroid cancer survivor who was diagnosed and treated for the condition at age 27, Sackhoff will be joining nationally recognized thyroid expert Dr. Jeffrey Garber for a satellite media tour
The blood glucose monitoring initiative will be uniquely structured to gather input from all major stakeholders involved in the diabetes arena and will examine critical factors such as regulatory challenges, post-FDA-approval monitoring of safety and accuracy of glucose strips, glucose sensors and devices, patient access and economic/reimbursement issues.
We are very pleased that the expanded USPSTF guidelines are now more aligned with our organization’s clinical guidelines
In recent years, medical journals and consumer publications alike have been hashing out the controversy about salt consumption and its effects on an array of medical conditions, primarily high blood pressure and heart disease, but also osteoporosis, kidney stones and kidney disease, and obesity.
In 2011, the American Association of Clinical Endocrinologists (AACE) Board of Directors declared obesity a disease state. And in 2013, the American Medical Association (AMA) agreed, approving an AACE-sponsored resolution on the floor of its House of Delegates. While many understood this to be a pivotal moment in the battle to curtail and reduce historic obesity rates, the question then heard most often was, “What happens next?”